Clinical Trial Update: A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE) [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated a simplification strategy using unboosted atazanavir (Reyataz) with abacavir/lamivudine (Epzicom) in HIV infection; the study compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Epzicom (abacavir/lamivudine)
• REYATAZ (atazanavir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 4 | Status: COMPLETED | Results posted: 2012-12-31